Atezolizumab is a medication used in this trial to help the immune system attack cancer cells. It works by blocking a protein that prevents the immune system from effectively fighting cancer. This medication is being tested in combination with other treatments to see if it can improve outcomes for patients with advanced solid tumors.

EIK1001 (BDB001) is an experimental drug in this trial that acts as a Toll-like receptor agonist. It is designed to stimulate the immune system to recognize and attack cancer cells more effectively. This medication is being tested alongside atezolizumab and radiotherapy to evaluate its potential benefits in treating various types of advanced cancers.

Immunogenic Radiotherapy is a type of radiation treatment used in this trial to target and destroy cancer cells. The goal of this therapy is to not only kill cancer cells directly but also to make them more recognizable to the immune system, enhancing the effects of the other treatments being tested in the study.

Pancreatic Cancer – Pancreatic cancer is a disease where malignant cells form in the tissues of the pancreas, an organ located behind the stomach. It often progresses silently, with symptoms appearing only in advanced stages. As the cancer grows, it can spread to nearby organs and lymph nodes. The disease can cause symptoms like jaundice, weight loss, and abdominal pain. It is known for its aggressive nature and difficulty in early detection.

Virus-Associated Tumors – These tumors are linked to infections by certain viruses, such as human papillomavirus (HPV) or Epstein-Barr virus (EBV). The viruses can cause changes in the cells, leading to uncontrolled growth and tumor formation. These tumors can occur in various parts of the body, depending on the virus involved. They may progress slowly or rapidly, depending on the type and location. Symptoms vary widely based on the tumor’s location and size.

Non-Small Cell Lung Cancer – Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for about 85% of cases. It typically grows and spreads more slowly than small cell lung cancer. NSCLC can cause symptoms like a persistent cough, chest pain, and shortness of breath. As it progresses, it may spread to other parts of the body, including the bones and brain. The disease is often diagnosed at an advanced stage due to subtle early symptoms.

Soft-Tissue Sarcomas – Soft-tissue sarcomas are a group of cancers that begin in the tissues that connect, support, or surround other structures and organs of the body. These can include muscles, fat, blood vessels, nerves, tendons, and the lining of the joints. They can occur anywhere in the body but are most common in the arms, legs, and trunk. The tumors may grow slowly or quickly, and symptoms depend on the tumor’s size and location.

Bladder Cancer – Bladder cancer begins in the cells of the bladder, the organ that stores urine. It often starts in the urothelial cells that line the inside of the bladder. The disease can cause symptoms such as blood in the urine, frequent urination, and pain during urination. As it progresses, it may invade deeper layers of the bladder wall and spread to nearby lymph nodes and organs. The progression can vary, with some tumors growing slowly and others more aggressively.

Triple Negative Breast Cancer – Triple negative breast cancer is a type of breast cancer that does not have the three common receptors known to fuel most breast cancer growth: estrogen, progesterone, and the HER-2/neu gene. It tends to be more aggressive and has fewer treatment options compared to other breast cancer types. The cancer can spread quickly to other parts of the body, including the lymph nodes and organs. Symptoms may include a lump in the breast, changes in breast shape, and skin dimpling.